SEC Form 4 · accession 0001127602-16-045138
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Mar 2, 2016
Accepted (ET)
Mar 4, 2016 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2016 | M | 20,072 | $59.41 | A | 403,708 | D | |
| Common Stock | Mar 2, 2016 | S | 20,072 | $75.00 | D | 383,636 | D | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $59.41 | Mar 2, 2016 | M | 20,072 | D | Feb 28, 2015 | Feb 28, 2021 | Common Stock | 20,072 | 40,143 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.